Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome (Q44513021)

3 December 2017

Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

Christie M. Ballantyne

2

object named as

Christie M Ballantyne

1 reference

3 December 2017

Donald B Hunninghake

1

1 reference

3 December 2017

Darbie L Maccubbin

3

1 reference

3 December 2017

Arvind K Shah

4

1 reference

3 December 2017

Barry Gumbiner

5

1 reference

3 December 2017

Yale B Mitchel

6

1 reference

3 December 2017

1 June 2003

1 reference

3 December 2017

Clinical Therapeutics

1 reference

3 December 2017

25

1 reference

3 December 2017

1670-1686

1 reference

3 December 2017

6

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Triglycerides and atherogenic lipoproteins: rationale for lipid management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Cholesterol reduction yields clinical benefit: impact of statin trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Waist circumference as a measure for indicating need for weight management.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Low density lipoprotein particle size and risk factors of insulin resistance syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Small LDL, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

The role of small, dense low density lipoprotein (LDL): a new look

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980162-5

7 January 2021

10.1016/S0149-2918(03)80162-5

Identifiers

DOI

1 reference

3 December 2017

1 reference